Top Sell
| Security | Buy | Sell | Buy (1M) | Sell (1M) | Price | Target price | Potential |
|---|---|---|---|---|---|---|---|
| Ryman Healthcare Group Ltd. | 1 | 1 | 0 | 0 | €2.17 | - | - |
| Cytomx Therapeutics Inc | 2 | 2 | 2 | 2 | €4.15 | €50.00 | 1104.819% |
| Integra LifeSciences Holdings Corp | 3 | 3 | 0 | 0 | €27.00 | €45.73 | 69.374% |
| Agenus Inc. | 2 | 2 | 0 | 0 | €0.41 | €7.30 | 1664.911% |
| Bayer AG ADR | 1 | 1 | 0 | 0 | €6.70 | €7.00 | 4.478% |
| B.R.A.I.N. Biotechnology Research and Information Network AG | 1 | 1 | 0 | 0 | €2.79 | €30.00 | 975.269% |
| Corbus Pharmaceuticals Holding Inc. | 2 | 1 | 2 | 0 | €35.60 | €50.00 | 40.449% |
| Roche Holding AG ADR | 2 | 1 | 0 | 0 | €27.74 | €38.00 | 36.993% |
| Novavax Inc. | 3 | 2 | 0 | 0 | €4.44 | €12.00 | 170.514% |
| Carl Zeiss Meditec AG | 2 | 1 | 0 | 0 | €97.95 | €101.00 | 3.114% |
| Omnicell Inc. | 3 | 2 | 1 | 0 | €25.20 | €35.45 | 40.690% |
| Orasure Tech | 3 | 1 | 0 | 1 | €4.92 | €8.36 | 69.884% |
| Formycon AG | 3 | 1 | 0 | 0 | €41.90 | €100.00 | 138.663% |
| Palisade Bio Inc. | 3 | 1 | 2 | 1 | €0.34 | €21.06 | 6072.333% |
| Merck KGaA | 3 | 1 | 0 | 0 | €152.60 | €146.00 | -4.325% |
| scPharmaceuticals | 3 | 1 | 0 | 1 | €4.14 | €16.43 | 296.870% |
| Sage Therapeutics Inc. | 5 | 3 | 1 | 1 | €12.22 | €26.71 | 118.705% |
| Corvus Pharmaceuticals Inc | 4 | 1 | 0 | 1 | €1.44 | €5.10 | 253.377% |
| Elanco Animal Health Inc. | 6 | 3 | 0 | 0 | €12.33 | €15.50 | 25.783% |
| Evotec SE | 4 | 1 | 0 | 0 | €9.83 | €21.50 | 118.830% |
| Chimerix Inc. | 4 | 1 | 0 | 0 | €0.92 | €5.51 | 497.465% |
| QuidelOrtho Corp. | 6 | 2 | 0 | 0 | €37.20 | €75.48 | 102.914% |
| Ocuphire Pharma Inc. | 5 | 1 | 0 | 0 | €1.73 | €18.30 | 957.572% |
| Karyopharm Therapeutics Inc. | 7 | 2 | 0 | 0 | €1.03 | €3.65 | 255.694% |
| Pacific Biosciences of California Inc. | 10 | 5 | 3 | 2 | €1.68 | €10.20 | 509.236% |